MedPath

AIN SHAMS UNIVERSITY

AIN SHAMS UNIVERSITY logo
🇪🇬Egypt
Ownership
Private
Established
1950-01-01
Employees
10K
Market Cap
-
Website
http://net.shams.edu.eg

Dexmedetomidine Versus Morphine and Midazolam in Prevention and Treatment of Delirium After Adult Cardiac Surgery

Phase 4
Completed
Conditions
Delirium
Interventions
First Posted Date
2017-03-14
Last Posted Date
2023-07-25
Lead Sponsor
Ain Shams University
Target Recruit Count
60
Registration Number
NCT03078946

Sofosbuvir and Simeprevir Versus Sofosbuvir and Ribavirin in Treatment of HCV

Phase 4
Completed
Conditions
HCV
Interventions
Drug: Sofosbuvir-Simeprevir
Drug: Sofosbuvir-Ribavirin
First Posted Date
2017-03-03
Last Posted Date
2017-03-03
Lead Sponsor
Ain Shams University
Target Recruit Count
90
Registration Number
NCT03069001

Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis Patients

Phase 2
Conditions
Chronic Hepatitis c
Interventions
Drug: Ombitasvir, Paritaprevir and Ritonavir
First Posted Date
2017-03-01
Last Posted Date
2018-01-18
Lead Sponsor
Ain Shams University
Target Recruit Count
40
Registration Number
NCT03067883
Locations
🇪🇬

Maadi armed forces hospital, Cairo, Maadi, Egypt

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

Phase 3
Completed
Conditions
Placenta Previa
Interventions
First Posted Date
2017-02-23
Last Posted Date
2017-02-23
Lead Sponsor
Ain Shams University
Target Recruit Count
86
Registration Number
NCT03060889

Long-term Hemodialysis Catheter Removal and Delayed Replacement, Versus Exchange Over a Guidewire to Treat Catheter Related Blood Stream Infection

Not Applicable
Completed
Conditions
Catheter Related Blood Stream Infection
Interventions
Device: catheter replacement
First Posted Date
2017-02-16
Last Posted Date
2017-02-23
Lead Sponsor
Ain Shams University
Target Recruit Count
798
Registration Number
NCT03054714

Sildenafil Citrate of in Vitro Fertilization After Multiple IVF Failures Attributed to Poor Endometrial Development

Phase 4
Conditions
IVF Failure
Interventions
Drug: Sildenafil Citrate
Drug: matching placebo
First Posted Date
2017-02-07
Last Posted Date
2017-02-07
Lead Sponsor
Ain Shams University
Target Recruit Count
80
Registration Number
NCT03044561
Locations
🇪🇬

Ain shams university, Cairo, Egypt

Folic Acid Supplementation as an Appetizer in Primary Malnourished Egyptian Infants and Children

Phase 4
Conditions
Primary Malnurtrition
Interventions
First Posted Date
2017-02-02
Last Posted Date
2017-03-14
Lead Sponsor
Ain Shams University
Target Recruit Count
100
Registration Number
NCT03040219
Locations
🇪🇬

Marian girgis, Cairo, Egypt

Golgi Protein for HCC Diagnosis

Completed
Conditions
Screening for Hepatocellular Carcinoma
Interventions
Diagnostic Test: Serum Golgi Protein 73
First Posted Date
2017-02-01
Last Posted Date
2017-02-01
Lead Sponsor
Ain Shams University
Target Recruit Count
90
Registration Number
NCT03039322

Misoprostol Before Elective Caesarean Section for Decreasing the Neonatal Respiratory Morbidity

Not Applicable
Conditions
Transient Tachypnea Newborn
Cesarean Delivery Affecting Fetus
Interventions
Drug: Placebos
Drug: Misoprostol
First Posted Date
2017-01-25
Last Posted Date
2018-05-29
Lead Sponsor
Ain Shams University
Target Recruit Count
170
Registration Number
NCT03031353
Locations
🇪🇬

Faculty of Medicine, Ain Shams University, Cairo, Al Qahirah, Egypt

Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants?

Phase 1
Conditions
Endocrine Disease
Fertility Decreased Male
DNA Damage
Interventions
First Posted Date
2017-01-09
Last Posted Date
2017-01-09
Lead Sponsor
Ain Shams University
Target Recruit Count
30
Registration Number
NCT03014882
Locations
🇪🇬

Ain Shams University, Cairo, Egypt

🇪🇬

Ain Shams University Hospitals, Cairo Governorate, Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath